Dr. Martin Lee is a Board certified in Internal Medicine and Medical Oncology with experienced in private and group medical oncology practices. Dr. Lee previously served as Executive Director/Vice President, Site and Patient Recruitment, at PPD, Inc.
Mark Levonyak has broad pharmaceutical industry experience, including new product planning and commercialization. Mark’s experience includes launching three oncology products (Kytril, Hycamtin, Trisenox).
Description
Slower than anticipated enrollment in cancer clinical trials is a common problem. In this white paper showcase, we will describe the unique challenges in cancer trials and efforts that have been made to increase enrollment. Recommendations for best practice and areas for further research will be highlighted.
Brought to you by DAVA Oncology, LP.
**Attendee badges scanned for this White Paper Showcase will be shared with the Company hosting this offering. If you prefer not to have your badge scanned, please inform the DIA staff member.
Learning Objectives: Describe the unique challenges encountered conducting clinical research in cancer patients Discuss the critical importance of site selection to successful trial enrollment Identify best practices for accelerating enrollment in cancer clinical trials.